Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2018

Mar 2, 2018

29828_dirs_2018-03-02_c5f76570-508c-4bd8-abf4-f2d86d2f526f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-02-21

Reporting Person: Washington Robin L (EVP, CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-21 Common Stock G 340 Disposed 23749 Direct
2018-02-21 Common Stock G 340 Acquired 103817 Indirect
2018-02-28 Common Stock G 6588 Disposed 17161 Direct
2018-02-28 Common Stock G 6588 Acquired 110405 Indirect
2018-02-28 Common Stock S 5000 $80.3132 Disposed 105405 Indirect

Footnotes

F1: Shares gifted to family trust.

F2: Open market sale from family trust shares

F3: Sale prices reported for the transactions reported here range from $80.311 to $80.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.